Intestinal permeability and blood clot risk in IBD
Part of Blood & lymphatic, Digestive system clinical trials.
This study looks at how a leaky gut might increase the risk of blood clots and blood vessel damage in people with inflammatory bowel disease (IBD). It may help researchers understand new ways to prevent complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Crohn's disease or ulcerative colitis (IBD).
- Your IBD is currently active or in remission (quiet stage).
- You are 18 years or older.
- You are willing and able to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether people with inflammatory bowel disease (IBD) have a higher risk of blood clots when the disease is active versus in remission. It may help understand how to better prevent clotting problems.
This study looks at changes in fats (lipids) in the blood and the lining of the gut in people with inflammatory bowel disease (IBD). It may help researchers understand IBD better and find new ways to treat it.
This study collects blood, stool, tissue, and health information from people with inflammatory bowel disease (IBD), their relatives, and healthy volunteers to find patterns that may help diagnose or treat IBD better in the future.
This study looks at cardiovascular risks in people with inflammatory bowel disease (IBD), like ulcerative colitis or Crohn's disease. It may help understand how IBD affects heart health.
This study looks at blood stem cells in children with inflammatory bowel disease (IBD) or rectal bleeding, compared with healthy children. It aims to understand why the immune system attacks the gut, which could lead to new treatments.
This study is looking at how the immune system works in people with inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis. By comparing blood or tissue samples from people with and without IBD, researchers hope to find better ways to treat the disease in the future.
Hear when a new IBD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.